FDA Posts Nationwide Recall of Papaverine Injection After Visible Particles Found
The FDA posted a nationwide recall for one lot of papaverine injection after visible glass or paraformaldehyde particles were found in the prescription drug.
Drug Safety
-
-
FDA Proposes Drug-Facility Rules to Improve Supply-Chain Visibility
A proposed FDA rule would give regulators more information on distributed drug makers and certain foreign suppliers, but patients and pharmacies see no immediate change.
